Legal & General Group
DFTX

Legal & General Group’s Definium Therapeutics DFTX Stock Holding History

Legal & General Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Sell
59,799
-7,176
-11% -$122K ﹤0.01% 2100
2025
Q4 		$897K Buy
66,975
+11,956
+22% +$148K ﹤0.01% 2249
2025
Q3 		$649K Sell
55,019
-1,684
-3% -$15.7K ﹤0.01% 2369
2025
Q2 		$368K Sell
56,703
-590
-1% -$3.88K ﹤0.01% 2525
2025
Q1 		$335K Sell
57,293
-1,144
-2% -$8.19K ﹤0.01% 2519
2024
Q4 		$407K Buy
58,437
+762
+1% +$5.24K ﹤0.01% 2533
2024
Q3 		$328K Buy
57,675
+4,442
+8% +$30.9K ﹤0.01% 2588
2024
Q2 		$384K Buy
+53,233
New +$466K ﹤0.01% 2508
2023
Q1 		– Sell
-1,025
Closed -$2.25K – 3389
2022
Q4 		$2.25K Sell
1,025
-2,957
-74% -$8.21K ﹤0.01% 3390
2022
Q3 		$13K Buy
3,982
+989
+33% +$9.49K ﹤0.01% 3299
2022
Q2 		$29K Sell
2,993
-2,644
-47% -$33.5K ﹤0.01% 3122
2022
Q1 		$96K Buy
5,637
+2,004
+55% +$34.8K ﹤0.01% 2882
2021
Q4 		$78K Buy
3,633
+54
+2% +$1.72K ﹤0.01% 2956
2021
Q3 		$129K Buy
3,579
+137
+4% +$5.92K ﹤0.01% 2798
2021
Q2 		$182K Buy
+3,442
New +$181K ﹤0.01% 2558

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Legal & General Group's DFTX Position: Q1 2026 in Review

Legal & General Group reduced its Definium Therapeutics (DFTX) stake by 11% in Q1 2026, selling an estimated $122K and leaving 59,799 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2100.

Legal & General Group first reported a position in DFTX in Q2 2021 and has held it in 15 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Legal & General Group held 59,799 shares of Definium Therapeutics worth $1.13M as of Q1 2026.
  • Legal & General Group sold 7,176 Definium Therapeutics shares in Q1 2026, an estimated $122K.
  • Definium Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2100 holding.
  • Legal & General Group first reported a position in Definium Therapeutics in Q2 2021 and has held it in 15 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.